<DOC>
	<DOCNO>NCT00776165</DOCNO>
	<brief_summary>A Phase III Randomized Controlled Open Label Comparative Multicentric Trial To Compare The Safety And Efficacy Indigenous Recombinant Human Granulocyte Colony Stimulating Factor ( rhG-CSF ) With Neupogen In Patients Myelosuppressive Therapy Non Myeloid Malignancies . Adult patient ( 18 year age old ) diagnose malignancy ( except myeloid malignancy , ECOG status 0-2 history experience neutropenia ( absolute neutrophil count &lt; 1000/mm3 ) previous chemotherapy cycle one cycle chemotherapy drug would recruit study . Treatment initiate earlier 24 hour administration cytotoxic chemotherapy group . Group 1 : Recombinant Human Granulocyte Colony Stimulating Factor ( rhG-CSF ) ( Shantha ) - Dose : 300 mcg/day administer subcutaneous/intravenous/continuous subcutaneous infusion minimum 7 day maximum 14 day till Neutrophil count 10,000/mm3 reach whichever early Group 2 : Neupogen ( rhG-CSF ) - Dose : 300mcg/day administer subcutaneous/intravenous/continuous subcutaneous infusion minimum 7 day maximum 14 day till Neutrophil count 10,000/mm3 reach whichever early Primary End Point would evaluate percentage patient develop febrile neutropenia ( define body temperature ≥ 38.2°C develop temperature &gt; 38°C twice 12-hour period absolute neutrophil count &lt; 0.5 x 109/L day fever day ) two treatment group .</brief_summary>
	<brief_title>Safety Efficacy Trial Recombinant Human Granulocyte Colony Stimulating Factor ( GCSF )</brief_title>
	<detailed_description />
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Patients either sex age 18 yr Patients diagnosed malignancy ( except myeloid malignancy myelodysplastic syndrome ) receive standard combination chemotherapy . Patients experience neutropenia ( absolute neutrophil count &lt; 1000/mm3 ) previous chemotherapy cycle one cycle chemotherapy drug . Patients performance status 02 ECOG ( European Cooperative Oncology group ) . Patients unwilling give inform consent unable follow study procedures Patients require autologous allogenic stem cell transplantation . Patients active infection Patients take antibiotic colony stimulation factor within previous 10 day Patients clinically significant uncontrolled medical illness except malignancy Patients renal impairment ( serum creatinine &gt; 1.5 time upper normal limit ) abnormal liver function ( bilirubin &gt; 5 time upper limit normal ) Pregnant lactate woman Patients involvement bone marrow Patients receive simultaneous radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>